Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Future directions should prioritize RCTs targeting early-stage glaucoma, with primary endpoints encompassing both structural (e.g., OCT-based RGC metrics) and functional (e.g., visual field preservation) outcomes, to validate the potential of GLP-1RAs as a true disease-modifying strategy in glaucoma management
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018
Hean AC et al
Whats real: NAD biology is scientifically valid
Valence specificity If GLP-1 RAs attenuate neural responses to both appetitive and aversive stimuli, this pattern could indicate a generalized dampening of emotional reactivity
Singh S, Khera R, Allen AM, Murad MH, Loomba R
US$ 29.39
US$ 24.00
US$ 27.95
US$ 26.08
US$ 23.54
